HCV Disease Progression
CROI 2017: Are HIV/HCV Coinfected People Cured with DAAs at Increased Risk for Liver Cancer?
- Details
- Category: HCV Disease Progression
- Published on Friday, 17 February 2017 00:00
- Written by Liz Highleyman
HIV/HCV coinfected people who are successfully treated for hepatitis C using interferon-free direct-acting antiviral (DAA) therapy do not appear to have an increased likelihood of developing hepatocellular carcinoma (HCC), according to a study presented at the Conference on Retroviruses and Opportunistic Infections this month in Seattle.
AASLD 2016: Is DAA Treatment for Hepatitis C Reducing the Need for Liver Transplants?
- Details
- Category: HCV Disease Progression
- Published on Sunday, 22 January 2017 00:00
- Written by Liz Highleyman
Patients successfully treated for hepatitis are less likely to need liver transplants and less likely to die while on a transplant waiting list, according to studies presented at the recent AASLD Liver Meeting. A related analysis looked at the optimal timing of treatment for people awaiting transplants in order to avoid "MELD purgatory."
AASLD 2016: Liver Cirrhosis and Decompensation on the Rise Among People with Hepatitis C
- Details
- Category: HCV Disease Progression
- Published on Tuesday, 17 January 2017 00:00
- Written by Liz Highleyman
Complications of advanced liver disease including cirrhosis and hepatic decompensation have risen over the past decade among people with chronic hepatitis C, according to study findings presented at the AASLD Liver Meeting in November. However, in recent years the increase has slowed, especially among those at highest risk -- black patients and people age 60 and over.
AASLD 2016: Curing Hepatitis C Reduces Liver-Related Complications and Death
- Details
- Category: HCV Disease Progression
- Published on Wednesday, 18 January 2017 00:00
- Written by Liz Highleyman
People with hepatitis C who achieve sustained virological response to treatment had lower liver-related morbidity and mortality rates compared to patients who were not successfully treated, according to research presented at the recent AASLD Liver Meeting.
AASLD 2016: Curing Hepatitis C May Help Reduce Kidney Disease Progression
- Details
- Category: HCV Treatment
- Published on Thursday, 15 December 2016 00:00
- Written by Liz Highleyman
People who achieved sustained virological response to interferon-based hepatitis C treatment experienced significantly less decline in kidney function, especially if they had liver cirrhosis, according to study findings presented at the 2016 AASLD Liver Meeting last month in Boston.
More Articles...
- AASLD 2016: Portal Hypertension Less Likely to Improve After HCV Treatment When Fibrosis Is Severe
- Coverage of the 2016 AASLD Liver Meeting
- HIV Coinfection Not a Risk Factor for Liver Fibrosis Progression in People with Hepatitis C
- EASL 2016: People Treated for Hepatitis C Have Unexpectedly High Rate of Liver Cancer Recurrence
Web Design and Development by